In conclusion, our findings suggest that astrocyte ephrinB2 upregulation is both a signaling mechanism underlying astrocyte pathogenicity in mutant SOD1-associated ALS and a promising therapeutic target. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.